These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 19695409

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A, Felisi M, Catapano M, Baiardi P, Cipollina L, Ravera S, Bagnulo S, Reggio S, Rondini G.
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [Abstract] [Full Text] [Related]

  • 3. New antibiotics: optimal use in current clinical practice.
    Karageorgopoulos DE, Falagas ME.
    Int J Antimicrob Agents; 2009 Nov; 34 Suppl 4():S55-62. PubMed ID: 19931821
    [Abstract] [Full Text] [Related]

  • 4. Optimizing therapy for vancomycin-resistant enterococci (VRE).
    Linden PK.
    Semin Respir Crit Care Med; 2007 Dec; 28(6):632-45. PubMed ID: 18095227
    [Abstract] [Full Text] [Related]

  • 5. Europe learns from US drug mistakes.
    Alcorn K.
    J Int Assoc Physicians AIDS Care; 1996 Mar; 2(3):39. PubMed ID: 11363346
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic indications in oncology: emerging features and regulatory dynamics.
    Tafuri G, Leufkens HG, Laing R, Trotta F.
    Eur J Cancer; 2010 Feb; 46(3):471-5. PubMed ID: 20056536
    [Abstract] [Full Text] [Related]

  • 7. Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication.
    Boucher HW.
    Clin Infect Dis; 2010 Jan 01; 50 Suppl 1():S4-9. PubMed ID: 20067391
    [Abstract] [Full Text] [Related]

  • 8. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency.
    Bottomley A, Jones D, Claassens L.
    Eur J Cancer; 2009 Feb 01; 45(3):347-53. PubMed ID: 19013787
    [Abstract] [Full Text] [Related]

  • 9. Recent drug approvals from the US FDA and EMEA: what the future holds.
    Pevarello P.
    Future Med Chem; 2009 Apr 01; 1(1):35-48. PubMed ID: 21426069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New antimicrobial agents approved by the U.S. Food and Drug Administration in 2004 and new indications for previously approved agents.
    Antimicrob Agents Chemother; 2005 May 01; 49(5):2151. PubMed ID: 15855554
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Unapproved uses of approved drugs: the physician, the package insert, and the Food and Drug Administration: subject review. American Academy of Pediatrics Committee on Drugs.
    Pediatrics; 1996 Jul 01; 98(1):143-5. PubMed ID: 8668390
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of oncology drugs at the European Medicines Agency and US Food and Drug Administration: when differences have an impact on clinical practice.
    Trotta F, Leufkens HG, Schellens JH, Laing R, Tafuri G.
    J Clin Oncol; 2011 Jun 01; 29(16):2266-72. PubMed ID: 21537038
    [Abstract] [Full Text] [Related]

  • 17. Review of oncology and hematology drug product approvals at the US Food and Drug Administration between July 2005 and December 2007.
    Sridhara R, Johnson JR, Justice R, Keegan P, Chakravarty A, Pazdur R.
    J Natl Cancer Inst; 2010 Feb 24; 102(4):230-43. PubMed ID: 20118413
    [Abstract] [Full Text] [Related]

  • 18. Non-clinical Post-Marketing Commitments for newly licenced pharmaceuticals.
    Reeve LM.
    Regul Toxicol Pharmacol; 2009 Nov 24; 55(2):181-7. PubMed ID: 19589365
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. How bacteraemia is reviewed by medicines licensing authorities in Europe.
    Toivonen M.
    Int J Antimicrob Agents; 2007 Nov 24; 30 Suppl 1():S103-7. PubMed ID: 17884354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.